Teva partners with Israeli institutes for early-stage drug research

Teva Pharmaceutical Industries on Monday signed research agreements with two leading Israeli academic institutes, a move to boost its early-stage drug development with a focus on cancer treatments.

from Reuters: Health News https://ift.tt/37v5yut